Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-001113
Filing Date
2025-02-27
Accepted
2025-02-27 10:58:55
Documents
20
Period of Report
2025-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_022725.htm 6-K 72343
2 GRAPHIC logo.jpg GRAPHIC 77729
3 GRAPHIC ca.jpg GRAPHIC 24896
4 GRAPHIC exh991_01.jpg GRAPHIC 334918
5 GRAPHIC exh991_02.jpg GRAPHIC 198836
6 GRAPHIC exh991_03.jpg GRAPHIC 126580
7 GRAPHIC exh991_04.jpg GRAPHIC 237228
8 GRAPHIC exh991_05.jpg GRAPHIC 252490
9 GRAPHIC exh991_06.jpg GRAPHIC 146544
10 GRAPHIC exh991_07.jpg GRAPHIC 221563
11 GRAPHIC exh991_08.jpg GRAPHIC 252109
12 GRAPHIC exh991_09.jpg GRAPHIC 181348
13 GRAPHIC exh991_10.jpg GRAPHIC 209676
14 GRAPHIC exh991_11.jpg GRAPHIC 147124
15 GRAPHIC exh991_12.jpg GRAPHIC 136178
16 GRAPHIC exh991_13.jpg GRAPHIC 135158
17 GRAPHIC exh991_14.jpg GRAPHIC 150450
18 GRAPHIC exh991_15.jpg GRAPHIC 121083
19 GRAPHIC exh991_16.jpg GRAPHIC 80108
20 GRAPHIC exh991_17.jpg GRAPHIC 34557
  Complete submission text file 0001171843-25-001113.txt   4298623
Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filer) CIK: 0000353278 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-82318 | Film No.: 25674723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)